Amazon’s new healthcare approach mines medical records

Amy Baxter | | Health Exec | Digital Transformation

Amazon is now selling software that “mines” medical records of patients to find ways to improve care and lower costs for providers, according to a report from The Wall Street Journal.

Amazon has several other forays into the healthcare space, including a joint venture with Berkshire Hathaway and JPMorgan Chase to create a new entity that focuses on improving healthcare for employees of the three companies.

The latest move takes aim at a market worth more than $7 billion a year, to store and analyze health information, according to the report. The software reads digitized patient records using deep learning to find specific data points.

Demand for this capability is likely to increase.

See the full story below:

Big Tech Expands Footprint in Health

Amy Baxter
Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Related Content

Nat’l Academy of Medicine sets ‘priorities for action’ as healthcare mulls next moves with AI
5 benefits of AI-enabled EHR systems
AI in the ICU (and elsewhere): Less stress, better conditions, alleviated shortages
4 ways HHS plans to help shape a national strategy for healthcare AI
Forging ahead with enterprise AI? Don’t wait to bring in your cybersecurity people
FDA to hopeful marketers of AI-equipped medical devices: Think beyond your initial approval

Around the web

AI in Healthcare
Nat’l Academy of Medicine sets ‘priorities for action’ as healthcare mulls next moves with AI

Given the precarious excitement of the moment—or is it exciting precarity?—policymakers and healthcare leaders must set directives guiding not only what to do with AI but also when to do it. 

Cardiovascular Business
Biden chooses semaglutide for next round of Medicare price negotiations—Trump gets final say

The final list also included diabetes drugs sold by Boehringer Ingelheim and Merck. The first round of drug price negotiations reduced the Medicare prices for 10 popular drugs by up to 79%. 

AI in Healthcare
4 ways HHS plans to help shape a national strategy for healthcare AI

HHS has thought through the ways AI can and should become an integral part of healthcare, human services and public health. Last Friday—possibly just days ahead of seating a new secretary—the agency released a detailed plan for getting there from here.